Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              A Prospective, Observational Study to Evaluate the Long-term Safety, Including Cardiovascular Safety, of Fremanezumab in Patients with Migraine in Routine Clinical Practice

              Author:Kahan, Natan   Krasenbaum, Lynda   Braverman, Debra   Barash, Steve   Colilla, Susan   Jennissen, Katja   Nellailingam, Roshini   Rainville, Carolyn   Ramirez Campos, Verena   Frain, Jill   Akcicek, Hasan   JM, Pramod   

              Session Name:P8: Headache: Advances in CGRP Inhibition 2  

              Topic:Headache  

              Program Number:P8.007  

              Author Institution:Teva Branded Pharmaceutical Industries Ltd., Netanya, Israel  Teva Branded Pharmaceutical Products R&D Inc., West Chester, PA  Teva Pharmaceuticals International GmbH, Rapperswil-Jona, Switzerland  Teva UK Ltd., Harlow, United Kingdom  Teva Netherlands B.V., Amsterdam, Netherlands  Teva Pharmaceutical Industries Ltd., Karnataka, India